NO20052854D0 - Substituerte alkylpyridazinoner for behandlingen av hukommelses- og laeresvikt. - Google Patents

Substituerte alkylpyridazinoner for behandlingen av hukommelses- og laeresvikt.

Info

Publication number
NO20052854D0
NO20052854D0 NO20052854A NO20052854A NO20052854D0 NO 20052854 D0 NO20052854 D0 NO 20052854D0 NO 20052854 A NO20052854 A NO 20052854A NO 20052854 A NO20052854 A NO 20052854A NO 20052854 D0 NO20052854 D0 NO 20052854D0
Authority
NO
Norway
Prior art keywords
pyridazinones
memory
treatment
substituted alkyl
learning failure
Prior art date
Application number
NO20052854A
Other languages
English (en)
Other versions
NO20052854L (no
Inventor
Aniko Miklosne Kovacs
Jozsef Barkoczy
Janos Wellmann
Laszlo Gabor Harsing
Peter Kotay Nagy
Gyorgy Levay
Andras Egyed
Gyula Simig
Gabor Szenasi
Bernadett Martonne Marko
Csilla Leveleki
Hajnalka Kompagne
Istvan Gacsalyi
Eva Schmidt
Original Assignee
Egyt Gyogyszervegyeszeti Gyar
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Egyt Gyogyszervegyeszeti Gyar filed Critical Egyt Gyogyszervegyeszeti Gyar
Publication of NO20052854D0 publication Critical patent/NO20052854D0/no
Publication of NO20052854L publication Critical patent/NO20052854L/no

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/14Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16Anti-Parkinson drugs
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/28Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Psychology (AREA)
  • Epidemiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
NO20052854A 2002-11-13 2005-06-13 Substituerte alkylpyridazinoner for behandlingen av hukommelses- og laeresvikt. NO20052854L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
HU0203929A HU227592B1 (en) 2002-11-13 2002-11-13 Use of substituted alkyl-piridazinone derivatives for the treatment of memory decline and learning malfunctions
PCT/HU2003/000096 WO2004043465A1 (en) 2002-11-13 2003-11-13 Substituted alkyl-pyridazinones for the treatment of memory and learning malfunctions

Publications (2)

Publication Number Publication Date
NO20052854D0 true NO20052854D0 (no) 2005-06-13
NO20052854L NO20052854L (no) 2005-06-13

Family

ID=90001560

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052854A NO20052854L (no) 2002-11-13 2005-06-13 Substituerte alkylpyridazinoner for behandlingen av hukommelses- og laeresvikt.

Country Status (20)

Country Link
US (1) US20060211703A1 (no)
EP (1) EP1567159A1 (no)
JP (1) JP2006507316A (no)
CN (1) CN1729000A (no)
AU (1) AU2003286277A1 (no)
BG (1) BG109188A (no)
BR (1) BR0316286A (no)
CA (1) CA2504959A1 (no)
CZ (1) CZ2005316A3 (no)
EA (1) EA008412B1 (no)
HR (1) HRP20050483A2 (no)
HU (1) HU227592B1 (no)
IS (1) IS7873A (no)
MX (1) MXPA05005137A (no)
NO (1) NO20052854L (no)
PL (1) PL376952A1 (no)
RS (1) RS20050459A (no)
SK (1) SK692005A3 (no)
WO (1) WO2004043465A1 (no)
ZA (1) ZA200504452B (no)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN117425648A (zh) * 2021-03-12 2024-01-19 杭州英创医药科技有限公司 作为parp7抑制剂的化合物

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IE62890B1 (en) * 1988-12-06 1995-03-08 Hafslund Nycomed Pharma New piperazinylalkyl-3(2h)-pyridazinones process for the preparation thereof and the use thereof as agents lowering blood pressure
HU227237B1 (en) * 2001-09-27 2010-12-28 Egis Gyogyszergyar Nyilvanosan Muekoedoe Reszvenytarsasag Substituted alkylpyridazinone derivatives, process for their preparation, pharmaceutical compositions containing them

Also Published As

Publication number Publication date
WO2004043465A1 (en) 2004-05-27
AU2003286277A1 (en) 2004-06-03
JP2006507316A (ja) 2006-03-02
HRP20050483A2 (en) 2005-12-31
IS7873A (is) 2005-05-31
HU227592B1 (en) 2011-09-28
ZA200504452B (en) 2006-08-30
BR0316286A (pt) 2005-10-11
CZ2005316A3 (cs) 2005-11-16
EA200500794A1 (ru) 2005-10-27
BG109188A (en) 2006-02-28
EA008412B1 (ru) 2007-04-27
NO20052854L (no) 2005-06-13
HUP0203929D0 (en) 2003-01-28
HUP0203929A2 (en) 2007-09-28
CA2504959A1 (en) 2004-05-27
RS20050459A (en) 2007-11-15
US20060211703A1 (en) 2006-09-21
EP1567159A1 (en) 2005-08-31
CN1729000A (zh) 2006-02-01
MXPA05005137A (es) 2005-07-22
PL376952A1 (pl) 2006-01-09
SK692005A3 (sk) 2005-11-03

Similar Documents

Publication Publication Date Title
NO20034389D0 (no) Fremgangsmåte for utledning av data
NO20052469D0 (no) Inhibitorer av II-beta-hydroksysteroid-dehydrogenase type 1 og type 2.
IS7710A (is) Heterósýklísk setin píperasín til notkunar við meðferð á geðklofa
NO20053211D0 (no) Forbindelser for behandling av metabolske forstyrrelser.
NO20053041D0 (no) Behandling av diabetes.
NO20041452L (no) 17-beta-hydroksysteroid-dehydrogenase type 3-inhibitorer for behandling av androgenavhengige sykdommer.
NO20052894D0 (no) 4-tetrazolyl-4-fenylpiperidin-derivater for behandling av smerte
NO20052887D0 (no) Pyridazinonderivater som GSK-3Beta inhibitorer.
DE60331470D1 (de) Av-system
DE60322507D1 (de) Steuerbarer katheter oder dergleichen
LU92504I2 (fr) Fluopyram
NL1024447A1 (nl) Werkwijzen en inrichtingen voor afknottingscompensatie.
NO20052058D0 (no) Behandling av influensa.
IS7650A (is) Meðferð við nýrnabilun með beta-inferón
IS7599A (is) Heterósýklískir kínasatálmar
DE60205193D1 (de) Speicherleseverstärker
DK1342881T3 (da) Opskummet syrebehandlingsvæske
NO20040510L (no) Forankring av skruetype.
NO20053276D0 (no) Fremgangsmate og hjelpemiddel for pavisning av mykoplasma.
ITMI20030274A1 (it) Elemento correttore per l'articolazione tra femore e bacino.
NO20043445L (no) Kombinasjonsterapi for behandling av bakterielle infeksjoner
NO20054034D0 (no) Fremgangsmate for behandling av hypotyroidisme.
NO20040497L (no) Amidinderivater for behandling av amyloidose
NO20052854D0 (no) Substituerte alkylpyridazinoner for behandlingen av hukommelses- og laeresvikt.
SE0501015L (sv) Befuktning av liten mängdvara

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application